Original Article from The New England Journal of Medicine — Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
Fonte: Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis | NEJM
Ainda em fase 2, mas resultados promissores …
